- >=99.0 HPLCHPLC / MSIn stock
Research compound
CJC/IPA
CJC/IPA is a two-component research preparation pairing CJC no DAC (GHRH receptor agonist) with Ipamorelin (GHS-R1a agonist) in a single lyophilized format. The receptor specifications are non-overlapping: CJC no DAC drives the cAMP-PKA cascade; Ipamorelin is characterized against the phospholipase C pathway. Combination preparations of this class are used in GH-axis research where synergistic receptor crosstalk in pituitary cell models is the object of study. For laboratory research use only.
Specification
- CAS
- Blend
- Molecular weight
- Mixed
- Formula
- Blend
- Purity
- >=99.0 HPLC
- Storage
- -20 °C, lyophilized
Size
Research notes
What is CJC/IPA?
CJC/IPA is a synthetic research compound studied in laboratory settings. It is intended for in vitro research use only and is not for human or animal use.
What purity is Valitec Peptides's CJC/IPA?
Valitec Peptides supplies CJC/IPA at >=99.0% purity, verified by third-party HPLC analysis. A certificate of analysis is available on request.
How is CJC/IPA supplied?
CJC/IPA is supplied as a lyophilized powder in sealed research-grade vials, stored -20 °C, lyophilized, intended for in vitro and laboratory research use only.
For laboratory research use only. Not for human or veterinary use, and not for diagnostic or therapeutic use.